371 related articles for article (PubMed ID: 8388432)
1. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
[TBL] [Abstract][Full Text] [Related]
2. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
3. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of an Mls-1-specific monoclonal antibody.
Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
[TBL] [Abstract][Full Text] [Related]
5. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of Mls-1.
Beutner U; Rudy C; Huber BT
Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
[TBL] [Abstract][Full Text] [Related]
7. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
[TBL] [Abstract][Full Text] [Related]
9. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor.
Woodland DL; Smith HP; Surman S; Le P; Wen R; Blackman MA
J Exp Med; 1993 Feb; 177(2):433-42. PubMed ID: 8381156
[TBL] [Abstract][Full Text] [Related]
11. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
Held W; Waanders GA; MacDonald HR; Acha-Orbea H
Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
13. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
14. Physiologic expression of two superantigens in the BDF1 mouse.
Gollob KJ; Palmer E
J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
[TBL] [Abstract][Full Text] [Related]
15. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
[TBL] [Abstract][Full Text] [Related]
16. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
Rudy CK; Kraus E; Palmer E; Huber BT
J Exp Med; 1992 Jun; 175(6):1613-21. PubMed ID: 1316931
[TBL] [Abstract][Full Text] [Related]
17. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
18. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).
Held W; Shakhov AN; Waanders G; Scarpellino L; Luethy R; Kraehenbuhl JP; MacDonald HR; Acha-Orbea H
J Exp Med; 1992 Jun; 175(6):1623-33. PubMed ID: 1316932
[TBL] [Abstract][Full Text] [Related]
19. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
20. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
